Scientific Advisory Boards
Clinical experts across the U.S. inform Evolent’s high-value clinical pathways with their insights, analysis and real-world experience.
Evolent’s clinical pathways in oncology and cardiology are developed and maintained by company clinicians under the oversight of independent scientific advisory boards (SABs). These boards are comprised of noted academic and community-based specialist physicians who help ensure our solutions reflect both the latest clinical evidence and real-world results in the field.
These boards advise Evolent’s clinical programs in several ways, including:
- Providing guidance and making recommendations on clinical guidelines and high-value clinical pathways
- Giving advice and feedback on Evolent’s clinical decision support tools, to help it continually improve the provider experience
- Advising Evolent on trends beyond pathways, such as drug shortages, alternative payment plans, and regulatory and financial pressures
- Monitoring peer-reviewed publications and national meetings for potentially practice-changing developments in the field
- Following nationally recognized clinical guidelines for updates and/or revisions
Scientific Advisory Board Members
Many scientific advisory board members have granted permission to be included on this website. While these lists are not exhaustive, they help convey the expertise that informs our clinical pathways and policies.
Medical Oncology
- Amy Cripps, M.D.Healthcare ConsultantHealthcare Consultant
Dr. Amy Cripps is a board-certified medical oncologist whose consultancy specializes in treatment pathways, genomics/precision medicine and chronic care management, as well as other patient-centric programs for small oncology practices.
Before her current role, Dr. Cripps served from 2021 to 2023 as medical director of clinical programs at Verdi Oncology, an oncology practice management company focused on value. She previously practiced oncology with Verdi Oncology Texas from 2013 to 2021.
Dr. Cripps received her medical degree from University of Texas Houston Health Science Center in 2003. She later completed her internal medicine residency and chief residency at Alameda County Medical Center before completing medical oncology fellowship at University of California San Francisco.
- Samir Dalia, MDAttending Physician, Mercy Clinic-Joplin Oncology and HematologyAttending Physician, Mercy Clinic-Joplin Oncology and HematologySamir Dalia, MDAttending Physician, Mercy Clinic-Joplin Oncology and HematologyAttending Physician, Mercy Clinic-Joplin Oncology and Hematology
Dr. Samir Dalia is a practicing oncologist, researcher and clinical leader at Mercy Clinic in Joplin, Missouri.
Among other leadership roles, Dr. Dalia heads Mercy Health System’s Oncology Pharmacy and Therapeutics Specialty Council, which determines preferred regimens, makes decisions about cost savings for oncology therapies, manages drug shortages, and more.
With research interests focused on lymphomas, viruses and hematological malignancies, he is an author on more than 70 peer-reviewed journal articles, as well as numerous book chapters. Dr. Dalia is also an editor and reviewer for numerous medical journals. Among those, he sits on the editorial board of the Journal of Blood Disorders, Journal of Hematology, Blood Transfusions and Disorders, and the Journal of Secondary Cancer Epidemiology, where he is editor in chief.
Dr. Dalia has also served as principal investigator for Mercy Joplin for several oncology clinical trials.
A 2007 graduate of Northeast Ohio Medical University, Dr. Dalia completed an internal medicine residency at Alpert School of Medicine at Brown University and The Rhode Island Hospital, followed by a hematology and oncology fellowship at H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.
- Seth Hardy, MD, MBAAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical CenterAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical CenterSeth Hardy, MD, MBAAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical CenterAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical Center
Dr. Seth Hardy, an associate professor of radiology with the Penn State Cancer Institute, brings a unique combination of experience as a clinician, researcher, and patient to the work of improving oncology care.
His experience as a leukemia survivor who is currently enrolled in a Phase II trial at the National Institutes of Health has given him a patient's perspective on the delivery of hematology/oncology care, clinical trials and potential shortcomings of our medical system.
As a researcher, Dr. Hardy focuses on the intersection of hematology/oncology, imaging, patient-centered care and value creation. He is currently developing a pilot clinical trial in patients on checkpoint inhibitors to develop imaging biomarkers that may provide efficacy feedback inside the typical 16-week cycle for CT/MR iRECIST.
He is a peer reviewer for Applied Radiology and Clinical Imaging. He has also served on several committees with the American College of Radiology and as a board member of the Pennsylvania Radiological Society.
With a bachelor’s degree in biomedical engineering, a commercial pilot’s license and an MBA, Dr. Hardy brings perspectives from multiple fields to the work of improving oncology and health care in general.
- Scott Kruger, MD, FACPMedical Director, Virginia Oncology AssociatesMedical Director, Virginia Oncology AssociatesScott Kruger, MD, FACPMedical Director, Virginia Oncology AssociatesMedical Director, Virginia Oncology Associates
Dr. Kruger is medical director of Virginia Oncology Associates, an oncology and hematology practice with locations spanning southeastern Virginia and northeastern North Carolina.
Dr. Kruger is a graduate of Jefferson Medical School in Philadelphia, Pennsylvania. He served in the United States Army where he completed his internship and internal medicine residency at Walter Reed Medical Center in Washington, DC. He completed a fellowship in hematology/oncology at Letterman Army Medical Center, including studies in bone marrow transplant at Hutchinson Cancer Research Center.
Dr. Kruger is board certified in internal medicine, hematology and medical oncology. He served on numerous committees in both the U.S. and Europe and has been awarded both military and civilian honors which include: the Meritorious Service Medal (two), Army Achievement Medal, the Commander’s Award for Excellence, and the National Red Cross Volunteer Award. Dr. Kruger has also been involved in clinical trials and research and has developed numerous presentations. He was a Leukemia Society board member for many years and is an associate professor of medicine at Eastern Virginia Medical School (EVMS) and chairman of the EVMS Institutional Review Board.
- Mohit Narang, MDManaging Partner, Maryland Oncology HematologyManaging Partner, Maryland Oncology HematologyMohit Narang, MDManaging Partner, Maryland Oncology HematologyManaging Partner, Maryland Oncology Hematology
Dr. Mohit Narang is a board-certified medical oncologist and hematologist with extensive experience as a clinician, researcher and physician leader.
With more than 25 years of practice experience, his expertise includes blood cancers, such as leukemia, lymphoma and multiple myeloma, as well as nonmalignant blood disorders including anemia and coagulation abnormalities. He is also a general medical oncologist treating colorectal, lung, genitourinary and gastrointestinal cancers.
In addition to publishing numerous articles in peer-reviewed journals, Dr. Narang has served as principal investigator on more than 40 clinical trials assessing the efficacy and safety of cancer drugs and therapies.
As chair of the Pharmacy & Therapeutics Committee and Research for Maryland Oncology Hematology, Dr. Narang helps the 50-physician, 16-location practice to provide safe and efficient therapy and bring the most recent advances in cancer therapies to patients.
- Lisa Raff, PharmD, MSPharm, BCPS, BCOPVice President of Pharmacy Services, OneOncologyVice President of Pharmacy Services, OneOncologyLisa Raff, PharmD, MSPharm, BCPS, BCOPVice President of Pharmacy Services, OneOncologyVice President of Pharmacy Services, OneOncology
Dr. Lisa Raff is responsible for all clinical and operational matters related to drug management, strategic pharma and Pharmacy & Therapeutics Committee initiatives for OneOncology, a network of leading oncology practices. She leads the OneOncology Pathways Program, ensuring adherence to highest standards of efficacy, toxicity and cost for drug management. Dr. Raff is also responsible for all corporate pharmacy processes, including clinical evaluation of all drugs receiving new approvals, new indications, or publication of new data on behalf of the Pharmacy & Therapeutics Committee. Working closely with the OneOncology operations team to ensure the coordination of all OneOncology pharmacy services across the network, she serves as a OneOncology subject matter expert on all pharmacy-related issues and ensures the highest regulatory and accreditation standards possible through specialty pharmacy practices.
Dr. Raff graduated with her Doctor of Pharmacy from Drake University. She earned a Master of Science in Pharmacy from the University of Florida, with a major in Pharmaceutical Sciences and a concentration in Personalized Medicine. She completed a residency in Pharmacy Practice and Management and is board-certified in Pharmacotherapy and Oncology.
- Dr. James L. Wade, III, MD, FACP, FASCO, FACCCFounder, Cancer Care Specialists of IllinoisFounder, Cancer Care Specialists of IllinoisDr. James L. Wade, III, MD, FACP, FASCO, FACCCFounder, Cancer Care Specialists of IllinoisFounder, Cancer Care Specialists of Illinois
Dr. James Wade is a practicing medical oncologist/hematologist whose 40-year career in central Illinois has included patient care, clinical research, national leadership and patient advocacy. Starting as a solo practitioner in 1984, Dr. Wade has helped guide the growth and development of Cancer Care Specialists of Illinois (CCSI), a 20-physician integrated interdisciplinary network of four cancer centers and 25 satellite clinics in central and southern Illinois. CCSI has received the American Society of Clinical Oncology (ASCO) QOPI Certification for Clinical Excellence for more than 10 years, the Clinical Trials Participation Award twice, and the Conquer Cancer Award for its research initiatives.
Dr. Wade has been an active clinical scientist with leadership roles in the Southwest Oncology Group (SWOG), the National Surgical Adjuvant Breast and Bowel Project (NSABP), and the NRG Oncology research base. He has been a principal investigator of several National Cancer Institute (NCI)-sponsored cancer clinical trials, co-chair of the SWOG Symptom and Quality of Life Committee, a member of the Board of SWOG, NSABP and NRG, and a member of the NCI Implementation Committee, which helped streamline the national cancer clinical trials process. Dr. Wade also chaired the first NCI Central Institutional Review Board from 2003-2004 and later chaired the new Symptom and Quality of Life NCI IRB from 2014-2019.
Dr. Wade has advocated for the patient through his leadership in the Illinois Medical Oncology Society as one of its founders and first president, as well as through his work with the Association of Community Cancer Centers, where was also president. His advocacy work has contributed to passage of several bills, including federal legislation protecting seniors from arbitrary denials of appropriate cancer treatment and Illinois law improving access to cancer clinical trials.
Cardiovascular
- Vinh Q. Chau, MD, FACCCardiologist and Faculty Member, Advocate Heart Institute at Advocate Christ Medical CenterCardiologist and Faculty Member, Advocate Heart Institute at Advocate Christ Medical CenterVinh Q. Chau, MD, FACCCardiologist and Faculty Member, Advocate Heart Institute at Advocate Christ Medical CenterCardiologist and Faculty Member, Advocate Heart Institute at Advocate Christ Medical Center
Cardiologist Dr. Vinh Chau is a practicing heart failure cardiologist and faculty member at Advocate Heart Institute, Advocate Christ Medical Center in Oak Lawn, Illinois. Board certified in internal medicine, cardiology and advanced heart failure and transplantation, he has a clinical interest in cardiometabolic management in heart failure. Dr. Chau also is also site principal investigator for clinical trials and trainee-initiated research projects related to cardiovascular disease. An author of numerous peer-reviewed journal articles in his field, he also co-directs the monthly Advocate Christ Heart Failure Lecture Series and annual Advocate Christ Heart Failure Symposium.
Dr. Chau is a graduate of Virginia Commonwealth University (VCU) School of Medicine. Following an internal medicine residency at the Medical University of South Carolina, he completed a cardiology fellowship at VCU Medical Center, and then finished his training in advanced heart failure at Mount Sinai Hospital in New York City.
- Nihar Desai, MD, MPHAssociate Chief of the Section of Cardiovascular Medicine, Yale University School of MedicineAssociate Chief of the Section of Cardiovascular Medicine, Yale University School of MedicineNihar Desai, MD, MPHAssociate Chief of the Section of Cardiovascular Medicine, Yale University School of MedicineAssociate Chief of the Section of Cardiovascular Medicine, Yale University School of Medicine
Dr. Nihar Desai is an associate professor of medicine and associate chief of the Section of Cardiovascular Medicine at Yale University School of Medicine, an investigator at Yale’s Center for Outcomes Research and Evaluation, and executive director for value innovation at the Yale New Haven Health System Heart and Vascular Center. His interests focus on cardiovascular health services and comparative effectiveness research, examining patterns of care, identifying opportunities to improve clinical outcomes, and evaluating the impact of novel care delivery systems on cost and quality. In addition, he serves as a clinical consultant on the CMS acute myocardial infarction, heart failure, and coronary artery bypass graft surgery readmission and mortality measures.
He graduated with highest honors from Lehigh University before completing an internship in the Clinton White House. He then earned a medical degree from the University of Connecticut School of Medicine before earning a master’s from the Harvard School of Public Health. Dr. Desai completed his residency in internal medicine as well as his clinical fellowship in cardiovascular medicine at Brigham and Women’s Hospital and Harvard Medical School. He then completed a research fellowship at the TIMI Study Group with Dr. Eugene Braunwald. His scholarly work has been published in New England Journal of Medicine, Journal of the American Medical Association, Circulation, and the Journal of the American College of Cardiology.
- Ashvin Pande, MDDirector of Invasive Cardiology and Cardiac Catheterization Laboratory, Boston Medical CenterDirector of Invasive Cardiology and Cardiac Catheterization Laboratory, Boston Medical CenterAshvin Pande, MDDirector of Invasive Cardiology and Cardiac Catheterization Laboratory, Boston Medical CenterDirector of Invasive Cardiology and Cardiac Catheterization Laboratory, Boston Medical Center
Dr. Ashvin N. Pande is a clinical associate professor of medicine at Boston University School of Medicine and attending physician at Boston Medical Center, where he is director of Invasive Cardiology and the Cardiac Catheterization Laboratory. He oversees quality, performance and medical education in the interventional cardiology section, has clinical expertise in complex coronary, peripheral vascular, and advanced structural heart interventions, and has been instrumental in the development of institutional interdisciplinary programs in valvular heart disease and venous thromboembolism.
A graduate of Harvard College and Duke University School of Medicine, Dr. Pande completed post-graduate training in internal medicine, cardiovascular medicine and interventional cardiology at Harvard Medical School and Brigham and Women’s Hospital in Boston. Board certified in internal medicine, cardiovascular disease, interventional cardiology and endovascular medicine, Dr. Pande is a member of the American College of Cardiology and a Fellow of the Society for Cardiovascular Angiography and Interventions. He has served as site principal investigator for national trials in carotid and peripheral arterial disease and revascularization and pulmonary embolism. Dr Pande has also been active in global health over the past 20 years, including educational, service and teaching programs to Tanzania, Kenya, Uganda, Cuba and China, with a focus on program development in interventional cardiology.
- Behzad Pavri, MD, FACC, FHRSProfessor of Medicine, Thomas Jefferson University HospitalProfessor of Medicine, Thomas Jefferson University HospitalBehzad Pavri, MD, FACC, FHRSProfessor of Medicine, Thomas Jefferson University HospitalProfessor of Medicine, Thomas Jefferson University Hospital
Dr. Behzad Pavri is a cardiac electrophysiologist, a professor of medicine, researcher and educator at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania with about 40 years of experience. With a focus on electrophysiology, he is an author of more than 100 peer-reviewed journal articles, as well as numerous book chapters and abstracts in the field. Dr. Pavri also is a peer reviewer for several leading journals in cardiology.
Dr. Pavri has directed electrophysiology fellowship training programs for three decades, including at Thomas Jefferson University Hospital since 2001. His teaching efforts with medical students, interns and fellows have earned him multiple awards for educational excellence throughout his career.
Dr. Pavri obtained his medical education at the Seth G.S. Medical College, University of Bombay, India and had his internship and residency training in internal medicine at the Harlem Hospital Center, at Columbia University in New York. He completed his cardiology fellowship at the Columbia Presbyterian Medical Center and his electrophysiology training at Massachusetts General Hospital in Boston.
Musculoskeletal
- Nomen Azeem, MD, FAAPMRFounder and CEO, Florida Spine and Pain SpecialistsFounder and CEO, Florida Spine and Pain SpecialistsNomen Azeem, MD, FAAPMRFounder and CEO, Florida Spine and Pain SpecialistsFounder and CEO, Florida Spine and Pain Specialists
Dr. Nomen Azeem is an interventional pain and physical medicine and rehabilitation specialist who has distinguished himself as a practitioner, clinical leader and researcher. He is founder and CEO of Florida Spine and Pain Specialists, which introduced the first successful non-opioid based interventional pain clinic to the Sarasota area. His approach emphasizes engages patients and their families in developing treatment plans so that they understand the cause of the patient’s pain and available treatment options.
Dr. Azeem holds several leadership positions in his field, including: chair of the Foundation of Innovative Spine Procedures, World Academy of Pain Medicine United; president of the Southeastern Society of Pain Intervention; board member of the Florida Prescription Drug Monitoring Program Foundation; and board member of the American Society of Pain and Neuroscience.
He has authored dozens of peer-reviewed articles, textbook chapters and posters on topics in his field. He has also served also principal investigator on multiple studies assessing the efficacy and safety of new pain interventions, including several ongoing studies.
A graduate of Ross University School of Medicine, Dr. Azeem completed an internship at Medstar Harbor Hospital Center in Baltimore and a residency at Medstar Georgetown University Hospital Physical Medicine and Rehabilitation in Washington, DC, where he was the chief resident. After filling a faculty position at Medstar Georgetown University as a musculoskeletal medicine specialist, he went on to complete an ACGME interventional pain fellowship at Temple University Hospital in Philadelphia, under the guidance of internationally renowned pain physician Dr. Frank J. E. Falco. - Brett Carey, DPTPhysical Therapist and ConsultantPhysical Therapist and Consultant
Dr. Brett Carey is a licensed physical therapist who specializes in using computer-aided design and 3D printing to fabricate custom orthoses for hand and foot injuries. Dr. Carey owned his own private practice and also served as a practice management consultant for over a decade before transitioning to serve as an adjunct faculty member for Hawaii Pacific University’s Doctor of Physical Therapy Program. Clinically, he takes on specialty cases as needed, mostly for children with developmental conditions requiring custom medical devices.
Dr. Carey is also a financial advisor, assisting private practices and clinicians with retirement planning and investment selection. Dr. Carey is passionate about nonprofit organizations and currently serves as the board president for Project Expedite Justice, the finance chairman for the Nowell Family Foundation, and chairman for the Hawaii Island Community Health Center Foundation. - Joline Heo, MD, FACPMedical Director of Managed Care, Sutter East Bay Medical GroupMedical Director of Managed Care, Sutter East Bay Medical GroupJoline Heo, MD, FACPMedical Director of Managed Care, Sutter East Bay Medical GroupMedical Director of Managed Care, Sutter East Bay Medical Group
Dr. Joline Heo is a board-certified internal medicine physician and a fellow of the American College of Physicians. She serves as the medical director of managed care for Sutter East Bay Medical Group, a multi-specialty medical group in Northern California with over 300 physicians spanning more than 25 specialties.
In her role as medical director, she oversees quality improvement projects to help streamline and improve utilization management processes to ensure that managed care patients have a smooth experience in obtaining care from a robust network of providers. Her clinical practice focuses on primary care for adults and managing their chronic health conditions.
Dr. Heo is a graduate of the Boston University School of Medicine and completed her residency at the University of California, Davis. - Patrick Ives, DPTPhysical TherapistPhysical Therapist
Patrick Ives is an Illinois-based physical therapist with extensive experience managing orthopedic and neurologic conditions in both outpatient and home health settings. Drawing on deep knowledge of best practice clinical guidelines, he works closely with orthopedic surgeons to address patients’ surgical and non-surgical needs in a seamless care plan.
With a passion for improving the lives of patients in their own environments, Dr. Ives seeks to provide individualized, comprehensive care that enhances patients’ mobility, independence and overall well-being. He has significant experience working with rural homebound patients, and he works closely with healthcare teams to assess and plan ongoing care to improve patients’ outcome and quality of life.
He earned a Doctorate in Physical Therapy from Azusa Pacific University in 2018. - Matthew Walker, MDOrthopedic Surgeon, Charleston Area Medical CenterOrthopedic Surgeon, Charleston Area Medical CenterMatthew Walker, MDOrthopedic Surgeon, Charleston Area Medical CenterOrthopedic Surgeon, Charleston Area Medical Center
Dr. Matthew Walker is a board-certified orthopedic surgeon in Charleston, West Virginia, with more than 20 years of clinical experience. Specializing in spine surgery, he believes in fostering a more connected patient journey, by ensuring the most effective use of physical therapy, imaging, pain management, and surgical procedures.
Dr. Walker previously served as medical director of musculoskeletal surgery at Evolent, where he oversaw efforts to ensure coordinated, high-quality care for patients experiencing spine and joint pain, as well as other orthopedic conditions.
Dr. Walker received his medical degree from West Virginia University School of Medicine in Morgantown, receiving multiple awards including the Alpha Omega Alpha Honor Medical Society. He completed his residency in orthopedic surgery at Summa Health Systems, where he was also honored for his research contributions. Dr. Walker later completed an orthopedic spine fellowship at the Mayo Clinic in Rochester, Minnesota.
Radiology
- Shamoona Ahmed, MDVice Chief of Medicine, University Medical CenterVice Chief of Medicine, University Medical CenterShamoona Ahmed, MDVice Chief of Medicine, University Medical CenterVice Chief of Medicine, University Medical Center
Dr. Shamoona Ahmed is a practicing physician and clinical leader at University Medical Center (UMC), a 564-bed facility in Las Vegas, Nevada. In her role as vice chief of medicine, her duties include improving inpatient clinical services, ensuring evidence-based practice, and overseeing provider performance evaluations and credentialing. As a member of UMC’s Performance Improvement Committee, she has also contributed to efforts to improve patient outcomes and patient safety, as well as efficiency of operations.
Dr. Ahmed is experienced in complex care management in a variety of settings. Since 2012, she has practiced at UMC as a hospitalist, responsible for all aspects of admitting, managing and discharging general medicine and critical care patients, while coordinating closely with subspecialty physicians. She also manages complex patients with acute and chronic conditions for Encompass Rehabilitation Center in Las Vegas.
Dr. Ahmed received her medical degree from Baqai Medical College in Pakistan and completed a residency in internal medicine at UMC.
- Walter Forred, MDRetired Professor and Director of Geriatrics, University of California San Francisco at FresnoRetired Professor and Director of Geriatrics, University of California San Francisco at FresnoWalter Forred, MDRetired Professor and Director of Geriatrics, University of California San Francisco at FresnoRetired Professor and Director of Geriatrics, University of California San Francisco at Fresno
Dr. Walter Forred is a retired professor of family and community medicine and director of geriatrics at the University of California San Francisco at Fresno. He has over 50 years of experience in primary care and has been residency director at the University of Missouri-Kansas City and the University of Arizona-affiliated Phoenix Baptist Medical Center. He has extensive experience in family medicine, geriatric medicine and aviation medicine.
Dr. Forred has authored articles for peer-reviewed journals and contributed to the Oxford Textbook of Primary Care. He has been a series editor for the Radiologic Decision Making series, which was published in the Journal of the American Academy of Family Physicians, as well as a peer reviewer for Family Practice Management and the Journal of the American Academy of Family Physicians.
Dr. Forred earned his medical degree from the University of Kansas. He served his internship at the Letterman General Army Hospital at the Presidio of San Francisco and his residency at the Silas B. Hayes Army Hospital, Fort Ord, California. He also holds a Certificate in Healthcare Management Development from the Foster College of Business Administration, Bradley University, Peoria, Illinois.
- Seth Hardy, MD, MBAAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical CenterAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical CenterSeth Hardy, MD, MBAAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical CenterAssociate Professor, Department of Radiology, Penn State Health Milton S. Hershey Medical Center
Dr. Seth Hardy, an associate professor of radiology with the Penn State Cancer Institute, brings a unique combination of experience as a clinician, researcher, and patient to the work of improving oncology care.
His experience as a leukemia survivor who is currently enrolled in a Phase II trial at the National Institutes of Health has given him a patient's perspective on the delivery of hematology/oncology care, clinical trials and potential shortcomings of our medical system.
As a researcher, Dr. Hardy focuses on the intersection of hematology/oncology, imaging, patient-centered care and value creation. He is currently developing a pilot clinical trial in patients on checkpoint inhibitors to develop imaging biomarkers that may provide efficacy feedback inside the typical 16-week cycle for CT/MR iRECIST.
He is a peer reviewer for Applied Radiology and Clinical Imaging. He has also served on several committees with the American College of Radiology and as a board member of the Pennsylvania Radiological Society.
With a bachelor’s degree in biomedical engineering, a commercial pilot’s license and an MBA, Dr. Hardy brings perspectives from multiple fields to the work of improving oncology and health care in general.
- Jihad Kudsi, MD, ABOM, MBA, MSF, FASMBS, FACSChair of Department of Surgery, Duly Health and CareChair of Department of Surgery, Duly Health and CareJihad Kudsi, MD, ABOM, MBA, MSF, FASMBS, FACSChair of Department of Surgery, Duly Health and CareChair of Department of Surgery, Duly Health and Care
Dr. Jihad Kudsi is a bariatric surgeon, clinical leader, entrepreneur and author based in Chicago. He is chair of the Department of Surgery and a member of the Clinical Board of Directors at Duly Health and Care, the largest independent, multi-specialty physician-directed medical group in the Midwest. He also serves as the medical director of bariatric surgery at University of Chicago AdventHealth LaGrange Hospital. Board-certified in general surgery and obesity medicine, he has a special interest in laparoscopic and robotic general surgery, as well as bariatric surgery.
Beyond his clinical practice, Dr. Kudsi is a serial entrepreneur and co-founder of VitaTrends, a bariatric vitamin startup dedicated to addressing the unique nutritional needs of sleeve gastrectomy patients. He is also the author of a patient-focused book on sleeve gastrectomy surgery.
Dr. Kudsi earned his medical degree from Aleppo University in Syria, completed his general surgery residency at The George Washington University, and pursued a fellowship in minimally invasive surgery at Houston Methodist Hospital. In addition to his medical training, he holds an MBA and a Master of Finance from Indiana University.
- Chintan Modi, MDPresident, Premier Gastroenterology ConsultantsPresident, Premier Gastroenterology ConsultantsChintan Modi, MDPresident, Premier Gastroenterology ConsultantsPresident, Premier Gastroenterology Consultants
Dr. Chintan Modi is a board-certified gastroenterologist with nearly 20 years’ experience who specializes in all aspects of digestive diseases and diagnostic and therapeutic endoscopy. He has a special interest in managing complex liver diseases and inflammatory bowel diseases.
Dr. Modi obtained his medical degree from Smt. N.H.L. Municipal Medical College, India. He then completed his internal medicine residency and gastroenterology fellowship at Seton Hall University. Dr. Modi is president and founder of Premier Gastroenterology, a gastroenterology and hepatology private practice in Edison, New Jersey.
Dr. Modi is a clinical assistant professor at Hackensack Meridian School of Medicine in New Jersey. He is a member of the Executive Committee and Peer Review Committee at JFK University Medical Center, part of the Hackensack Meridian Health network. Dr. Modi also serves as a teaching faculty in the gastroenterology fellowship program at Bayonne Medical Center.
- Deepak Sudheendra, MD, MHCI, RPVI, FSIRFounder and Medical Director, 360 Vascular InstituteFounder and Medical Director, 360 Vascular InstituteDeepak Sudheendra, MD, MHCI, RPVI, FSIRFounder and Medical Director, 360 Vascular InstituteFounder and Medical Director, 360 Vascular Institute
Dr. Deepak Sudheendra (aka Dr. Sudi) is a board-certified vascular interventional radiologist and an international leader in the treatment of the complications of deep vein thrombosis (DVT) and peripheral artery disease, as well as other complex vascular conditions. He is the medical director of 360 Vascular Institute, the first nationally accredited office-based interventional radiology practice in Ohio that he founded in 2022 to focus on comprehensive, personalized vascular care. Previously, he served for more than a decade as founder and director of the DVT & Complex Venous Disease Program at the Hospital of the University of Pennsylvania. The program — which grew to be one of the largest of its kind in the United States — attracted patients from throughout the U.S. and internationally for treatment of complex vascular disease.
A prolific author of peer-reviews articles and book chapter in his field, Dr. Sudi has delivered numerous presentations internationally and across the U.S. He has also served as an investigator on multiple clinical trials in interventional radiology. Dr. Sudi has trained over 150 residents and fellows and has received awards for his dedication to teaching future physicians.
Dr. Sudi earned his medical degree from New York Medical College. After nearly four years of general surgery residency at Georgetown University, he completed an interventional radiology research fellowship at the National Institutes of Health. He went on to complete four years of diagnostic radiology residency at the University of Pittsburgh Medical Center, followed by a fellowship in vascular interventional radiology at the George Washington University Medical Center.
- Neelima Thakur, MDAssistant Professor of Neurology, Tufts University School of MedicineAssistant Professor of Neurology, Tufts University School of MedicineNeelima Thakur, MDAssistant Professor of Neurology, Tufts University School of MedicineAssistant Professor of Neurology, Tufts University School of Medicine
Dr. Neelima Thakur is a board-certified neurologist and epileptologist with over 15 years of experience in the diagnosis, monitoring and management of epilepsy. As an assistant professor of neurology at Tufts University School of Medicine, she specializes in advanced epilepsy care, including Video-EEG monitoring for seizure characterization, antiepileptic medication management, intracranial EEG evaluation, and epilepsy surgery assessment.
A graduate of Rangaraya Medical College in India, Dr. Thakur completed her neurology residency at the University of Nebraska Medical Center – Creighton University and pursued a fellowship in clinical neurophysiology at UT Southwestern Medical Center in Dallas, Texas.
Beyond clinical practice, Dr. Thakur is deeply committed to advancing epilepsy research, medical education and digital innovations in patient care. She actively mentors medical students and neurology residents while contributing to professional organizations and strategic initiatives that shape the future of epilepsy treatment.
In addition to her expertise in neurology, Dr. Thakur is currently training in integrative medicine and Ayurveda, seeking to incorporate holistic approaches into epilepsy and neurological disorder management. Her dedication to blending modern neuroscience with integrative therapies underscores her mission to enhance patient care through comprehensive, evidence-based treatment strategies.
The scientific advisory board was put together to bring physicians and other experts – patient advocates, pharmacists – to the table to take this very pristine set of data and interpret it through a real-world lens of what’s applicable, what is not yet ready for prime time, and interpret that so that the guidelines have a very day-to-day relevance, rather than something that’s just a theory written in a paper.
We’ve had a number of situations where we have proposed a clinical pathway for a certain scenario in cancer care, based on clinical trials. And a majority of our advisory board members have recommended against it. They may have used that regimen previously, with all sorts of side effects, or had patients end up in the hospital. We’ve then decided not to put those regimens on our pathway, based on this real-world experience. So, the board’s input very much alters the final product of the pathways we put out there.